The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
Open accessAbstract
BACKGROUND: Physicians commonly screen for prostate cancer by using prostate-specific antigen (PSA) and digital rectal examination (DRE). The usefulness of these screening mechanisms is not well established, however. A meta-analysis of PSA and DRE to detect prostate carcinoma was conducted with a focus on sensitivity, specificity, and positive predictive value. METHODS: A literature search of OVID database (1966 to November 1999) using the medical subject headings "prostate-specific antigen" and "mass screening," as well as "prostate carcinoma," was performed. Thirteen articles were selected for the meta-analysis in this study. Most studies included asymptomatic men older than 50 years from various countries. Pooled results were calculated from the individual reports for sensitivity, specificity, and positive predictive value for PSA and DRE based on biopsy result as the reference standard. RESULTS: The overall detection rate of prostate carcinoma was 1.8% based on a positive biopsy. Of the prostate carcinoma detected, 83.4% was localized. The pooled sensitivity, specificity, and positive predictive value for PSA were 72.1%, 93.2% and 25.1%, respectively; and for DRE were 53.2%, 83.6% and 17.8%, respectively. CONCLUSIONS: There were two major outcomes of this meta-analysis. One was the potential for detecting early-stage prostate cancer with these screening tests, because 83.4% of total cancers detected were localized. The second important outcome was that the overall sensitivity, specificity, and positive predictive value for PSA were higher than those for DRE when used as a screening tool to detect prostate cancer. When a patient has abnormal findings using PSA and DRE, the chance of cancer is 1 in 4 or 5. Conversely, when findings from PSA and DRE are normal, the chance of missing a cancer is about 10%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Statistical Abstract of the United States: 1960.
F., R. (1961) · Journal of the American Statistical Association · doi:10.2307/2282384 · Cited by 2,581
Statistical Abstract of the United States: 2007
(2007) · Choice Reviews Online · doi:10.5860/choice.45-1769 · Cited by 2,398
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Guide to Clinical Preventive Services
&NA; (1997) · The Nurse Practitioner · doi:10.1097/00006205-199705000-00020 · Cited by 906
Guide to Clinical Preventive Services: A Challenge to Physician Resourcefulness
Haber, D. (1993) · Clinical Gerontologist · doi:10.1300/j018v12n03_03 · Cited by 447
de Koning, H. J., Auvinen, A., Berenguer Sanchez, A., Calais da Silva, F., Ciatto, S., Denis, L., Gohagan, J. K., Hakama, M., Hugosson, J., Kranse, R., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.1588 · Cited by 285
Prostate Cancer Screening: What We Know and What We Need To Know
Kramer, B. S., Brown, M. L., Prorok, P. C., Potosky, A. L., & Gohagan, J. K. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00009 · Cited by 273
Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
Woolf, S. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332107 · Cited by 240
The palpable nodule of prostatic cancer. Results 15 years after radical excision
Hj, J. (1968) · JAMA · doi:10.1001/jama.203.6.403 · Cited by 228
Cited by
Kadri, S. R., Lao-Sirieix, P., O'Donovan, M., Debiram, I., Das, M., Blazeby, J. M., Emery, J., Boussioutas, A., Morris, H., Walter, F. M., et al. (2010) · BMJ · doi:10.1136/bmj.c4372 · Cited by 322
Naji, L., Randhawa, H., Sohani, Z., Dennis, B., Lautenbach, D., Kavanagh, O., Bawor, M., Banfield, L., & Profetto, J. (2018) · The Annals of Family Medicine · doi:10.1370/afm.2205 · Cited by 271
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He, Y., Xu, W., Xiao, Y.-T., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 261
Deep Learning Role in Early Diagnosis of Prostate Cancer
Reda, I., Khalil, A., Elmogy, M., Abou El-Fetouh, A., Shalaby, A., Abou El-Ghar, M., Elmaghraby, A., Ghazal, M., & El-Baz, A. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533034618775530 · Cited by 119
Metadata
- Authors
- Mistry, K., & Cable, G.
- Venue
- The Journal of the American Board of Family Medicine
- Published
- 2003-03-01
- Volume
- 16
- Issue
- 2
- Pages
- 95-101
- ISSN
- 1557-2625 (ISSN-L)
- 1558-7118
- OpenAlex
- W2058532211
- Cited by
- 275
- References
- 16
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma. https://app.cochat.ai/papers/10.3122/jabfm.16.2.95
- The paper
- Mistry, K., & Cable, G. (2003). Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/jabfm.16.2.95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.